Termination of Agreement for Rifamycin SV MMX®with Dr. Falk Pharma
Cosmo Pharmaceuticals N.V. (“Cosmo”) today announced the termination by mutual agreement of the license with Dr. Falk Pharma for Rifamycin SV MMX® in the EU and other selective countries.